COVID
INPATIENT
>
CONSIDERATIONS & LABS
PAXLOVID
REMDESIVIR
OLUMIANT
ACTEMRA
STEROIDS
VTE
OUTPATIENT
Education
Bugs & Tips
Agents & Spectra
Guidelines
By Infection Type
Surgical Prophylaxis
>
By Procedure
Dosing Guide
Formulary
Antibiogram
2023 Inpatient
2023 Outpatient
2022 Inpatient
2022 Outpatient
2021 Inpatient
2021 Outpatient
2020 Inpatient
2019 Inpatient
2019 Outpatient
About
ASP Program
Stats & Data
>
Recommendations
Pharmacy Data
MDR ORGANISMS
DDD/DOT
Contact
lAGEVRIO (MOLNUPIRAVIR)
NOTES
If a patient is hospitalized before completing the 5-day course of Lagevrio, the course may be completed in the hospital at the attending provider's discretion. The patient will need to provide the drug themselves as it is not available at GVH.
MECHANISM & EVIDENCE
INDICATION & LIMITATIONS OF USE
CONTRAINDICATIONS, PRECAUTIONS & WARNINGS
ADVERSE EFFECTS
DOSING
COUNSELING
MEDWATCH REPORTING
REFERENCES
COVID
INPATIENT
>
CONSIDERATIONS & LABS
PAXLOVID
REMDESIVIR
OLUMIANT
ACTEMRA
STEROIDS
VTE
OUTPATIENT
Education
Bugs & Tips
Agents & Spectra
Guidelines
By Infection Type
Surgical Prophylaxis
>
By Procedure
Dosing Guide
Formulary
Antibiogram
2023 Inpatient
2023 Outpatient
2022 Inpatient
2022 Outpatient
2021 Inpatient
2021 Outpatient
2020 Inpatient
2019 Inpatient
2019 Outpatient
About
ASP Program
Stats & Data
>
Recommendations
Pharmacy Data
MDR ORGANISMS
DDD/DOT
Contact